E

ENOV

Enovis Corporation
$18.57
Current Price
AI analysis
Read what the AI thinks of Enovis Corporation in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app

Key figures

Dividend per share
—
Yield
—
EPS
-$19.27
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings
Before the open · Expected EPS: $0.79
Nov 5

Posts

No posts about ENOV yet.

About Enovis Corporation

Enovis Corporation designs and makes medical devices and equipment for orthopedics — think joint reconstruction implants, surgical instruments, and bracing/recovery products used by surgeons and physical therapists. It earns money by selling these devices to hospitals, clinics and distributors around the world, and has grown partly through acquisitions of other device makers.

Add ENOV to your watchlist

Add ENOV to your watchlist.
Scan with your iPhone camera: this page opens in the app.
  • Its AI analysis
  • Every story about it, live
  • An alert when a wallet trades it
Download on the App Store